GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (WBO:COLO) » Definitions » Price-to-Free-Cash-Flow

Coloplast AS (WBO:COLO) Price-to-Free-Cash-Flow : 29.09 (As of May. 24, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast AS Price-to-Free-Cash-Flow?

As of today (2025-05-24), Coloplast AS's share price is €84.36. Coloplast AS's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was €2.90. Hence, Coloplast AS's Price-to-Free-Cash-Flow Ratio for today is 29.09.

The historical rank and industry rank for Coloplast AS's Price-to-Free-Cash-Flow or its related term are showing as below:

WBO:COLO' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 29.05   Med: 47.98   Max: 187.05
Current: 29.05

During the past 13 years, Coloplast AS's highest Price-to-Free-Cash-Flow Ratio was 187.05. The lowest was 29.05. And the median was 47.98.

WBO:COLO's Price-to-Free-Cash-Flow is ranked worse than
50.81% of 372 companies
in the Medical Devices & Instruments industry
Industry Median: 28.445 vs WBO:COLO: 29.05

Coloplast AS's Free Cash Flow per Share for the three months ended in Mar. 2025 was €0.26. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €2.90.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Coloplast AS was 340.30% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -26.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -15.00% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -0.80% per year.

During the past 13 years, Coloplast AS's highest 3-Year average Free Cash Flow per Share Growth Rate was 44.10% per year. The lowest was -26.00% per year. And the median was 8.30% per year.


Coloplast AS Price-to-Free-Cash-Flow Historical Data

The historical data trend for Coloplast AS's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Price-to-Free-Cash-Flow Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.91 64.56 41.65 53.97 138.58

Coloplast AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 189.78 143.08 138.58 110.67 33.43

Competitive Comparison of Coloplast AS's Price-to-Free-Cash-Flow

For the Medical Instruments & Supplies subindustry, Coloplast AS's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Price-to-Free-Cash-Flow falls into.


;
;

Coloplast AS Price-to-Free-Cash-Flow Calculation

Coloplast AS's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=84.36/2.9
=29.09

Coloplast AS's Share Price of today is €84.36.
Coloplast AS's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.90.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Coloplast AS  (WBO:COLO) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Coloplast AS Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines